Skip to main content
. 2018 Aug 31;7(10):5107–5117. doi: 10.1002/cam4.1753

Figure 3.

Figure 3

Cumulative incidences of MMR, DMR, and EFS according to VEMR (≤40% and >40%) achievement at 4 wk. VEMR, very early molecular response; MMR, molecular response; DMR, deep molecular response; EFS, event‐free survival; y, year. *EFS‐a: PFS + ELN treatment failure + ELN warning. EFS‐b: PFS + ELN treatment failure + ELN warning + frontline TKI discontinuation (except treatment‐free remission)